SUSAN RAWL, professor of adult health at the Indiana University School of Nursing and a researcher at the IU Melvin and Bren Simon Cancer Center, received nearly $2.6 million from the Patient-Centered Outcomes Research Institute to compare interventions to increase colorectal cancer screening among underserved patients with limited resources. Rawl’s study was selected for PCORI...
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
